Spark gene therapy improves vision, at least in short term: FDA – Reuters
Kansas City Star |
Spark gene therapy improves vision, at least in short term: FDA
Reuters (Reuters) – Spark Therapeutics Inc’s experimental gene therapy for a rare inherited form of blindness improves vision, though it is unclear whether the benefit lasts over time, according to a preliminary review by the U.S. Food and Drug Administration. Correction: Genetic Frontiers-Blindness-Gene Therapy story The FDA is Considering a Landmark Approval of Gene Therapy To Cure Blindness Seeing hope: FDA panel considers gene therapy for blindness |
View original article
Author:
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.